1. Home
  2. NATR vs NLSP Comparison

NATR vs NLSP Comparison

Compare NATR & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NATR
  • NLSP
  • Stock Information
  • Founded
  • NATR 1972
  • NLSP 2015
  • Country
  • NATR United States
  • NLSP Switzerland
  • Employees
  • NATR N/A
  • NLSP N/A
  • Industry
  • NATR Biotechnology: Pharmaceutical Preparations
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • NATR Health Care
  • NLSP Health Care
  • Exchange
  • NATR Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • NATR 269.6M
  • NLSP 12.4M
  • IPO Year
  • NATR N/A
  • NLSP 2021
  • Fundamental
  • Price
  • NATR $15.91
  • NLSP $2.31
  • Analyst Decision
  • NATR Strong Buy
  • NLSP
  • Analyst Count
  • NATR 2
  • NLSP 0
  • Target Price
  • NATR $18.50
  • NLSP N/A
  • AVG Volume (30 Days)
  • NATR 120.8K
  • NLSP 378.8K
  • Earning Date
  • NATR 08-07-2025
  • NLSP 07-15-2025
  • Dividend Yield
  • NATR N/A
  • NLSP N/A
  • EPS Growth
  • NATR N/A
  • NLSP N/A
  • EPS
  • NATR 0.53
  • NLSP N/A
  • Revenue
  • NATR $456,619,000.00
  • NLSP N/A
  • Revenue This Year
  • NATR $3.08
  • NLSP N/A
  • Revenue Next Year
  • NATR $2.41
  • NLSP N/A
  • P/E Ratio
  • NATR $29.89
  • NLSP N/A
  • Revenue Growth
  • NATR 2.00
  • NLSP N/A
  • 52 Week Low
  • NATR $10.81
  • NLSP $1.30
  • 52 Week High
  • NATR $18.06
  • NLSP $15.59
  • Technical
  • Relative Strength Index (RSI)
  • NATR 64.71
  • NLSP 48.87
  • Support Level
  • NATR $13.39
  • NLSP $2.20
  • Resistance Level
  • NATR $16.23
  • NLSP $3.08
  • Average True Range (ATR)
  • NATR 0.52
  • NLSP 0.25
  • MACD
  • NATR 0.10
  • NLSP -0.05
  • Stochastic Oscillator
  • NATR 88.73
  • NLSP 16.36

About NATR Nature's Sunshine Products Inc.

Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: